Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates

Psychiatry Research

Volumn 209, Issue 3, 2013, Pages 459-465

  Lev Ran, Shaul ^a   Le Foll, Bernard ^a,b   McKenzie, Kwame ^a,b   George, Tony P ^a,b   Rehm, Jürgen ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bipolar disorder; Cannabis; Cannabis use disorders; Co morbidity; NESARC

Indexed keywords

CANNABIS;

ADULT; AGED; ANTISOCIAL PERSONALITY DISORDER; ARTICLE; BIPOLAR DISORDER; CANNABIS ADDICTION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TOBACCO DEPENDENCE;

BIPOLAR DISORDER; CANNABIS; CANNABIS USE DISORDERS; CO-MORBIDITY; NESARC;

ADOLESCENT; ADULT; BIPOLAR DISORDER; COMMUNITY HEALTH PLANNING; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; YOUNG ADULT;

EID: 84885473430     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.12.014     Document Type: Article

References (56)

1. Agrawal A., Nurnberger J.I., Lynskey M.T. Cannabis involvement in individuals with bipolar disorder. Psychiatry Research 2011, 185:459-461.
2. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, American Psychiatric Association, Washington DC, (Text Revision (DSM-IV-TR)). fourth edition.
3. Baethge C., Baldessarini R.J., Khalsa H.M., Hennen J., Salvatore P., Tohen M. Substance abuse in first-episode bipolar I disorder: indications for early intervention. American Journal of Psychiatry 2005, 162:1008-1010.
4. Bega S., Schaffer A., Goldstein B., Levitt A. Differentiating between Bipolar Disorder types I and II: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Affective Disorders 2012, 138:46-53.
5. Begley C.E., Annegers J.F., Swann A.C., Lewis C., Coan S., Schnapp W.B., Bryant-Comstock L. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001, 19:483-495.
6. Berk M., Dodd S. Bipolar II disorder: a review. Bipolar Disorders 2005, 7:11-21.
7. Brugha T.S., Bebbington P.E., Jenkins R. A difference that matters: comparisons of structured and semi-structured psychiatric diagnostic interviews in the general population. Psychological Medicine 1999, 29:1013-1020.
8. Carpenter D., Clarkin J.F., Glick I.D., Wilner P.J. Personality pathology among married adults with bipolar disorder. Journal of Affective Disorders 1995, 34:269-274.
9. Carter T.D., Mundo E., Parikh S.V., Kennedy J.L. Early age at onset as a risk factor for poor outcome of bipolar disorder. Journal of Psychiatric Research 2003, 37:297-303.
10. Cerullo M.A., Strakowski S.M. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Substance Abuse Treatment, Prevention and Policy 2007, 2:29.
11. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. Journal of the American Medical Association 2004, 291:2114-2121.
12. Dell'Osso B., Buoli M., Bortolussi S., Camuri G., Vecchi V., Altamura A.C. Patterns of Axis I comorbidity in relation to age in patients with Bipolar Disorder: a cross-sectional analysis. Journal of Affective Disorders 2011, 130:318-322.
13. Dunayevich E., Sax K.W., Keck P.E., McElroy S.L., Sorter M.T., McConville B.J., Strakowski S.M. Twelve-month outcome in bipolar patients with and without personality disorders. Journal of Clinical Psychiatry 2000, 61:134-139.
14. Etain B., Lajnef M., Bellivier F., Mathieu F., Raust A., Cochet B., Gard S., M'Bailara K., Kahn J.P., Elgrabli O., Cohen R., Jamain S., Vieta E., Leboyer M., Henry C. Clinical expression of bipolar disorder type I as a function of age and polarity at onset: convergent findings in samples from France and the United States. Journal of Clinical Psychiatry 2012, 73:e561-e566.
15. Fossey M.D., Otto M.W., Yates W.R., Wisniewski S.R., Gyulai L., Allen M.H., Miklowitz D.J., Coon K.A., Ostacher M.J., Neel J.L., Thase M.E., Sachs G.S., Weiss R.D. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. American Journal on Addictions 2006, 15:138-143.
16. Gao K., Tolliver B.K., Kemp D.E., Verduin M.L., Ganocy S.J., Bilali S., Brady K.T., Shim S.S., Findling R.L., Calabrese J.R. Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder. Journal of Affective Disorders 2008, 110:167-173.
17. Garno J.L., Goldberg J.F., Ramirez P.M., Ritzler B.A. Bipolar disorder with comorbid cluster B personality disorder features: impact on suicidality. Journal of Clinical Psychiatry 2005, 66:339-345.
18. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence 2003, 71:7-16.
19. Grant, B.F., Moore, T.C., Kaplan, K., 2003b. Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). National Institute on Alcohol Abuse and Alcoholism, Bethesda, Md.
20. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2004, 61:807-816.
21. Grant B.F., Stinson F.S., Hasin D.S., Dawson D.A., Chou S.P., Ruan W.J., Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2005, 66:1205-1215.
22. Grucza R.A., Abbacchi A.M., Przybeck T.R., Gfroerer J.C. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction 2007, 102:623-629.
23. Gunderson J.G., Weinberg I., Daversa M.T., Kueppenbender K.D., Zanarini M.C., Shea M.T., Skodol A.E., Sanislow C.A., Yen S., Morey L.C., Grilo C.M., McGlashan T.H., Stout R.L., Dyck I. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. American Journal of Psychiatry 2006, 163:1173-1178.
24. Henry C., Mitropoulou V., New A.S., Koenigsberg H.W., Silverman J., Siever L.J. Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. Journal of Psychiatric Research 2001, 35:307-312.
25. Huang, B., Grant, B.F., Dawson, D.A., Stinson, F.S., Chou, S.P., Saha, T.D., Goldstein, R.B., Smith, S.M., Ruan, W.J., Pickering, R.P., 2006. Race-ethnicity and the prevalence and co-occurrence of Diagnostic and Statistical Manual of Mental Disorders, fourth edition, Alcohol and Drug Use Disorders and Axis I and II disorders: United States, 2001 to 2002. Comprehensive Psychiatry 47, pp. 252-257.
26. Jagdeo A., Cox B.J., Stein M.B., Sareen J. Negative attitudes toward help seeking for mental illness in 2 population-based surveys from the United States and Canada. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2009, 54:757-766.
27. Kay J.H., Altshuler L.L., Ventura J., Mintz J. Impact of axis II comorbidity on the course of bipolar illness in men: a retrospective chart review. Bipolar Disorders 2002, 4:237-242.
28. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:617-627.
29. Klerman G.L. Diagnosis of psychiatric disorders in epidemiologic field studies. Archives of General Psychiatry 1985, 42:723-724.
30. Kosinski M., Turner-Bowker D.M., Gandek B., Ware J.E. User's Manual for the SF-12v2 Health Survey 2007, QualityMetric, Inc., Lincoln, RI.
31. Le Strat Y., Hoertel N. Correlation is no causation: gymnasium proliferation and the risk of obesity. Addiction 2011, 106:1871-1872.
32. Lev-Ran, S., Imtiaz, S., Taylor, B.J., Shield, K.D., Rehm, J., Le Foll, B., 2011. Gender differences in health-related quality of life among cannabis users: results from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence.
33. Lynskey M.T., Heath A.C., Bucholz K.K., Slutske W.S., Madden P.A., Nelson E.C., Statham D.J., Martin N.G. Escalation of drug use in early-onset cannabis users vs. co-twin controls. Journal of the American Medical Association 2003, 289:427-433.
34. McMillan K.A., Enns M.W., Cox B.J., Sareen J. Comorbidity of Axis I and II mental disorders with schizophrenia and psychotic disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2009, 54:477-486.
35. Michalak E.E., Yatham L.N., Lam R.W. Quality of life in bipolar disorder: a review of the literature. Health and Quality of Life Outcomes 2005, 3:72.
36. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
37. Narrow W.E., Rae D.S., Robins L.N., Regier D.A. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Archives of General Psychiatry 2002, 59:115-123.
38. O'Connell R.A., Mayo J.A., Sciutto M.S. PDQ-R personality disorders in bipolar patients. Journal of Affective Disorders 1991, 23:217-221.
39. Oquendo M.A., Currier D., Liu S.M., Hasin D.S., Grant B.F., Blanco C. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry 2010, 71:902-909.
40. Pica S., Edwards J., Jackson H.J., Bell R.C., Bates G.W., Rudd R.P. Personality disorders in recent-onset bipolar disorder. Comprehensive Psychiatry 1990, 31:499-510.
41. Post R.M., Weiss S.R.B. Neurobiological models of recurrence in mood disorders. Neurobiology of Mental Illness 1999, Oxford University Press, New York. D.S. Charney, E.J. Nestler, B.S. Bunney (Eds.).
42. Regier D.A., Kaelber C.T., Rae D.S., Farmer M.E., Knauper B., Kessler R.C., Norquist G.S. Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy. Archives of General Psychiatry 1998, 55:109-115.
43. Research Triangle Institute, 2004. Software for Survey Data Analysis (SUDAAN), 10 ed. Research Triangle Institute, Research Triangle Park, NC.
44. Smith K.W., Larson M.J. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. American Journal of Drug and Alcohol Abuse 2003, 29:323-335.
45. SPSS Inc., 2010. SPSS 19, Chicago, Ill, USA.
46. Strakowski S.M., DelBello M.P., Fleck D.E., Adler C.M., Anthenelli R.M., Keck P.E., Arnold L.M., Amicone J. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Archives of General Psychiatry 2007, 64:57-64.
47. Strakowski S.M., DelBello M.P., Fleck D.E., Arndt S. The impact of substance abuse on the course of bipolar disorder. Biological Psychiatry 2000, 48:477-485.
48. Supina A.L., Patten S.B. Self-reported diagnoses of schizophrenia and psychotic disorders may be valuable for monitoring and surveillance. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2006, 51:256-259.
49. Swann A.C. Antisocial personality and bipolar disorder: interactions in impulsivity and course of illness. Neuropsychiatry (London) 2011, 1:599-610.
50. Tohen M., Zarate C.A., Hennen J., Khalsa H.M., Strakowski S.M., Gebre-Medhin P., Salvatore P., Baldessarini R.J. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. American Journal of Psychiatry 2003, 160:2099-2107.
51. Turley B., Bates G.W., Edwards J., Jackson H.J. MCMI-II personality disorders in recent-onset bipolar disorders. Journal of Clinical Psychology 1992, 48:320-329.
52. van Rossum I., Boomsma M., Tenback D., Reed C., van Os J. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. Journal of Nervous and Mental Disease 2009, 197:35-40.
53. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34:220-233.
54. Woods S.W. The economic burden of bipolar disease. Journal of Clinical Psychiatry 2000, 61(Suppl. 13):38-41.
55. Wyatt R.J., Henter I. An economic evaluation of manic-depressive illness-1991. Social Psychiatry and Psychiatric Epidemiology 1995, 30:213-219.
56. Zanarini M.C., Frankenbur F.R., Weingeroff J.L., Reich D.B., Fitzmaurice G.M., Weiss R.D. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction 2011, 106:342-348.